BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35065173)

  • 1. Evaluating the impact of the COVID-19 pandemic on cancer screening in a central Canadian province.
    Decker KM; Feely A; Bucher O; Singh H; Turner D; Lambert P
    Prev Med; 2022 Feb; 155():106961. PubMed ID: 35065173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a National Quality Improvement Collaborative for Improving Cancer Screening.
    Joung RH; Mullett TW; Kurtzman SH; Shafir S; Harris JB; Yao KA; Bilimoria KY; Cance WG; Nelson H;
    JAMA Netw Open; 2022 Nov; 5(11):e2242354. PubMed ID: 36383381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba.
    Decker KM; Lambert P; Feely A; Bucher O; Kim JO; Hebbard P; Thiessen M; Fatoye T; Pitz M; Koul R; Czaykowski P
    Curr Oncol; 2021 Aug; 28(4):3081-3090. PubMed ID: 34436035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study.
    Walker MJ; Meggetto O; Gao J; Espino-Hernández G; Jembere N; Bravo CA; Rey M; Aslam U; Sheppard AJ; Lofters AK; Tammemägi MC; Tinmouth J; Kupets R; Chiarelli AM; Rabeneck L
    Prev Med; 2021 Oct; 151():106586. PubMed ID: 34217413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer incidence during the COVID-19 pandemic by region of residence in Manitoba, Canada: A cancer registry-based interrupted time series study.
    Decker KM; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Singh H; Thiessen M; Pitz M; Musto G; Galloway K; Lambert P
    Cancer Med; 2023 Dec; 12(23):21465-21479. PubMed ID: 37974380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
    Chen RC; Haynes K; Du S; Barron J; Katz AJ
    JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of COVID-19 in Cervical and Breast Cancer Screening and Systemic Treatment in São Paulo, Brazil: An Interrupted Time Series Analysis.
    Duarte MBO; Argenton JLP; Carvalheira JBC
    JCO Glob Oncol; 2022 Jun; 8():e2100371. PubMed ID: 35696624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruptions in preventive care: Mammograms during the COVID-19 pandemic.
    Song H; Bergman A; Chen AT; Ellis D; David G; Friedman AB; Bond AM; Bailey JM; Brooks R; Smith-McLallen A
    Health Serv Res; 2021 Feb; 56(1):95-101. PubMed ID: 33146429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures.
    Nyante SJ; Benefield TS; Kuzmiak CM; Earnhardt K; Pritchard M; Henderson LM
    Cancer; 2021 Jun; 127(12):2111-2121. PubMed ID: 33635541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitigating the impact of COVID-19 on colorectal cancer screening: Organized service screening perspectives from the Asia-Pacific region.
    Chiu HM; Su CW; Hsu WF; Jen GH; Hsu CY; Chen SL; Chen HH
    Prev Med; 2021 Oct; 151():106622. PubMed ID: 34044024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Cancer Diagnoses Before and During the COVID-19 Pandemic.
    Decker KM; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Pitz M; Singh H; Thiessen M; Lambert P
    JAMA Netw Open; 2023 Sep; 6(9):e2332363. PubMed ID: 37669049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term impact of the COVID-19 pandemic on a population-based screening program for colorectal cancer in Catalonia (Spain).
    Vives N; Binefa G; Vidal C; Milà N; Muñoz R; Guardiola V; Rial O; Garcia M
    Prev Med; 2022 Feb; 155():106929. PubMed ID: 34954239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring the impact of COVID-19 on cancer survival using an interrupted time series analysis.
    Lambert P; Galloway K; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Pitz M; Singh H; Thiessen M; Decker KM
    JNCI Cancer Spectr; 2024 Jan; 8(1):. PubMed ID: 38177077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparities in Same-Day Diagnostic Imaging in Breast Cancer Screening: Impact of an Immediate-Read Screening Mammography Program Implemented During the COVID-19 Pandemic.
    Dontchos BN; Achibiri J; Mercaldo SF; Wang GX; Lamb LR; Miles RC; Narayan AK; Lehman CD
    AJR Am J Roentgenol; 2022 Feb; 218(2):270-278. PubMed ID: 34494449
    [No Abstract]   [Full Text] [Related]  

  • 16. Cross-sectional survey of the impact of the COVID-19 pandemic on cancer screening programs in selected low- and middle-income countries: Study from the IARC COVID-19 impact study group.
    Villain P; Carvalho AL; Lucas E; Mosquera I; Zhang L; Muwonge R; Selmouni F; Sauvaget C; Basu P;
    Int J Cancer; 2021 Jul; 149(1):97-107. PubMed ID: 33533501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flemish population-based cancer screening programs: impact of COVID-19 related shutdown on short-term key performance indicators.
    Jidkova S; Hoeck S; Kellen E; le Cessie S; Goossens MC
    BMC Cancer; 2022 Feb; 22(1):183. PubMed ID: 35177021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic.
    Labaki C; Bakouny Z; Schmidt A; Lipsitz SR; Rebbeck TR; Trinh QD; Choueiri TK
    Cancer Cell; 2021 Aug; 39(8):1042-1044. PubMed ID: 34265251
    [No Abstract]   [Full Text] [Related]  

  • 19. Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada.
    Malagón T; Yong JHE; Tope P; Miller WH; Franco EL;
    Int J Cancer; 2022 Apr; 150(8):1244-1254. PubMed ID: 34843106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the COVID-19 pandemic on breast cancer screening volumes and patient screening behaviors.
    Miller MM; Meneveau MO; Rochman CM; Schroen AT; Lattimore CM; Gaspard PA; Cubbage RS; Showalter SL
    Breast Cancer Res Treat; 2021 Aug; 189(1):237-246. PubMed ID: 34032985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.